https://scholars.lib.ntu.edu.tw/handle/123456789/496127
標題: | Insulin use is not significantly predictive for prostate cancer mortality in diabetic patients: A 12-year follow-up study | 作者: | CHIN-HSIAO TSENG | 公開日期: | 2012 | 卷: | 110 | 期: | 5 | 起(迄)頁: | 668-673 | 來源出版物: | BJU International | 摘要: | Study Type - Prognosis (inception cohort) Level of Evidence 2a What's known on the subject? and What does the study add? Even though a lower risk of prostate cancer has been reported in patients with diabetes, they may have a higher risk of cancer development involving the liver, pancreas, endometrium, colorectum, breast and bladder. Insulin may have mitogenic properties besides its metabolic function. However, whether exogenous insulin use for glycaemic control in diabetic patients could increase the risk of prostate cancer has rarely been studied. This is the first prospective follow-up study for up to 12 years to show that exogenous insulin use for glycaemic control in the diabetic patients is not significantly predictive for prostate cancer mortality. Objective To evaluate whether insulin use in diabetic patients could be predictive for prostate cancer mortality. Patients and methods A total of 39 135 diabetic men aged ?40 years from a nationally representative cohort were followed prospectively from 1995 to 2006 for prostate cancer mortality. Cox proportional hazards models were used to estimate the hazard ratios for the following independent variables: age, diabetes type, diabetes duration, body mass index, smoking, insulin use and area of residence. The models were created for patients aged ?40 years and ?65 years, separately; and before and after excluding patients with a duration between onset of diabetes and prostate cancer mortality <5 years. Results A total of 105 diabetic men died of prostate cancer during follow-up. Age was the only significant risk factor. Insulin use was associated with an insignificantly higher risk of prostate cancer mortality ranging from 24% to 49%. When stratified by the duration of insulin use <5 and ?5 years, a lack of significant association was also observed. Conclusions Insulin use in diabetic patients does not significantly predict the mortality from prostate cancer. Further confirmation in other ethnicities is needed. ? 2012 BJU INTERNATIONAL. |
URI: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-84865347945&doi=10.1111%2fj.1464-410X.2011.10924.x&partnerID=40&md5=b8e2c41cd9aa17505e5e0b96ceac57cc https://scholars.lib.ntu.edu.tw/handle/123456789/496127 |
ISSN: | 1464-4096 | DOI: | 10.1111/j.1464-410X.2011.10924.x | SDG/關鍵字: | insulin; adult; age; article; body mass; cancer mortality; cohort analysis; diabetic patient; disease duration; drug use; ethnicity; follow up; geography; glycemic control; hazard ratio; human; hyperglycemia; independent variable; major clinical study; male; patient selection; predictive value; priority journal; proportional hazards model; prospective study; prostate cancer; risk factor; smoking; Adult; Aged; Aged, 80 and over; Diabetes Mellitus, Type 2; Humans; Hypoglycemic Agents; Insulin; Male; Middle Aged; Proportional Hazards Models; Prospective Studies; Prostatic Neoplasms; Risk Factors; Taiwan |
顯示於: | 醫學系 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。